{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:13:35Z","timestamp":1788491615920,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.iac.2017.04.006","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T01:00:54Z","timestamp":1499216454000},"page":"483-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema"],"prefix":"10.1016","volume":"37","author":[{"suffix":"Jr.","given":"Cosby","family":"Stone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.iac.2017.04.006_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.anai.2014.06.019","article-title":"Multinational experience with hypersensitivity drug reactions in Latin America","volume":"113","author":"Jares","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2017.04.006_bib2","first-page":"455","article-title":"Drug-induced angioedema: experience of Italian emergency departments","volume":"9","author":"Bertazzoni","year":"2014","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.iac.2017.04.006_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2500\/aap2008.29.3085","article-title":"Ten-year study of causes of moderate to severe angioedema seen by an inpatient allergy\/immunology consult service","volume":"29","author":"Banerji","year":"2008","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.iac.2017.04.006_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2015.06.021","article-title":"Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema","volume":"136","author":"Kowalski","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2500\/108854199778251799","article-title":"Diagnosis of pyrazolone drug sensitivity: clinical history versus skin testing and in\u00a0vitro testing","volume":"20","author":"Kowalski","year":"1999","journal-title":"Allergy Asthma Proc"},{"issue":"12","key":"10.1016\/j.iac.2017.04.006_bib6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1365-2222.2012.04078.x","article-title":"Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria","volume":"42","author":"Cornejo-Garcia","year":"2012","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/FPC.0000000000000216","article-title":"Copy number variation in ALOX5 and PTGER1 is associated with NSAIDs-induced urticaria and\/or angioedema","volume":"26","author":"Plaza-Seron Mdel","year":"2016","journal-title":"Pharmacogenet Genomics"},{"issue":"4","key":"10.1016\/j.iac.2017.04.006_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/all.12821","article-title":"Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review","volume":"71","author":"Oussalah","year":"2016","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.iac.2017.04.006_bib9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1067\/mai.2000.104571","article-title":"Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema","volume":"105","author":"Wong","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib10","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/bcp.13090","article-title":"Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink","volume":"82","author":"Mahmoudpour","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.iac.2017.04.006_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jama.1997.03550030072037","article-title":"Recurrent angiotensin-converting enzyme inhibitor\u2013associated angioedema","volume":"278","author":"Brown","year":"1997","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib12","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/HYPERTENSIONAHA.108.110270","article-title":"Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors","volume":"51","author":"Miller","year":"2008","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.iac.2017.04.006_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/0194599815588909","article-title":"Predictors of airway intervention in\u00a0angiotensin-converting enzyme inhibitor-induced angioedema","volume":"153","author":"Kieu","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"7","key":"10.1016\/j.iac.2017.04.006_bib14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1988.03410070095035","article-title":"Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition","volume":"260","author":"Slater","year":"1988","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.iac.2017.04.006_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.amjhyper.2003.09.014","article-title":"Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial","volume":"17","author":"Kostis","year":"2004","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.iac.2017.04.006_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1524-6175.2003.01924.x","article-title":"The African American Study of Kidney Disease and Hypertension (AASK) trial: what more have we learned?","volume":"5","author":"Sica","year":"2003","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"11","key":"10.1016\/j.iac.2017.04.006_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iac.2017.04.006_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0009-9236(96)90161-7","article-title":"Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema","volume":"60","author":"Brown","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1365-2125.1999.00093.x","article-title":"Angioedema due to ACE inhibitors: increased risk in patients of African origin","volume":"48","author":"Gibbs","year":"1999","journal-title":"Br J Clin Pharmacol"},{"issue":"14","key":"10.1016\/j.iac.2017.04.006_bib20","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","article-title":"Incidence and characteristics of angioedema associated with enalapril","volume":"165","author":"Kostis","year":"2005","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.iac.2017.04.006_bib21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaip.2013.05.003","article-title":"Pollen count and presentation of angiotensin-converting enzyme inhibitor-associated angioedema","volume":"1","author":"Straka","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.iac.2017.04.006_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1081-1206(10)62723-8","article-title":"Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients","volume":"82","author":"Abbosh","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"10.1016\/j.iac.2017.04.006_bib23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1398-9995.2010.02398.x","article-title":"Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use","volume":"65","author":"Byrd","year":"2010","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.iac.2017.04.006_bib24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Clinical practice. Hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2017.04.006_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pupt.2016.09.001","article-title":"Involvement of the TRPV1 receptor in plasma extravasation in airways of rats treated with an angiotensin-converting enzyme inhibitor","volume":"41","author":"de Oliveira","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.iac.2017.04.006_bib26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1124\/jpet.103.064105","article-title":"The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat","volume":"309","author":"Sulpizio","year":"2004","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib27","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.HYP.31.6.1299","article-title":"Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P","volume":"31","author":"Emanueli","year":"1998","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.iac.2017.04.006_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaci.2007.04.012","article-title":"Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema","volume":"120","author":"Byrd","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jch.12104","article-title":"Association of B2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South Africans","volume":"15","author":"Moholisa","year":"2013","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"1 Pt 1","key":"10.1016\/j.iac.2017.04.006_bib30","first-page":"134","article-title":"Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency","volume":"99","author":"Lung","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.04.006_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2125.2009.03567.x","article-title":"Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema","volume":"69","author":"Bas","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.iac.2017.04.006_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0301-0546(08)72537-0","article-title":"The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers","volume":"36","author":"Gulec","year":"2008","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"4","key":"10.1016\/j.iac.2017.04.006_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/496899","article-title":"A\u00a0variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors","volume":"77","author":"Duan","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.iac.2017.04.006_bib34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/FPC.0b013e32833d3acb","article-title":"Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema","volume":"20","author":"Woodard-Grice","year":"2010","journal-title":"Pharmacogenet Genomics"},{"issue":"9","key":"10.1016\/j.iac.2017.04.006_bib35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FPC.0b013e328363c137","article-title":"Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema","volume":"23","author":"Pare","year":"2013","journal-title":"Pharmacogenet Genomics"},{"issue":"9644","key":"10.1016\/j.iac.2017.04.006_bib36","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.iac.2017.04.006_bib37","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.amjmed.2005.06.040","article-title":"Risk of first-time hospitalization for angioedema among users of ACE inhibitors and angiotensin receptor antagonists","volume":"118","author":"Johnsen","year":"2005","journal-title":"Am J Med"},{"issue":"20","key":"10.1016\/j.iac.2017.04.006_bib38","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","article-title":"Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system","volume":"172","author":"Toh","year":"2012","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib39","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.anai.2011.08.015","article-title":"Randomized placebo-controlled trial of the bradykinin B(2) receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial","volume":"107","author":"Lumry","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.04.006_bib41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","article-title":"A\u00a0randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Bas","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2017.04.006_bib42","article-title":"Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema","author":"Straka","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.04.006_bib43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.annemergmed.2014.07.014","article-title":"Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial","volume":"65","author":"Lewis","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.iac.2017.04.006_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.anai.2014.12.007","article-title":"Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department","volume":"114","author":"Bernstein","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2017.04.006_bib45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/HYPERTENSIONAHA.109.134197","article-title":"Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema","volume":"54","author":"Brown","year":"2009","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.iac.2017.04.006_bib46","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.iac.2017.04.006_bib47","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1503\/cmaj.1041561","article-title":"Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study","volume":"172","author":"Hill","year":"2005","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.iac.2017.04.006_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/jnnp-2014-308097","article-title":"Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke","volume":"86","author":"Hurford","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.iac.2017.04.006_bib49","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ene.12472","article-title":"Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use","volume":"21","author":"Lin","year":"2014","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib50","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/01.STR.0000017284.77838.87","article-title":"Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in\u00a0vitro experimental approach","volume":"33","author":"Molinaro","year":"2002","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.iac.2017.04.006_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4168\/aair.2010.2.2.77","article-title":"Update on the management of antibiotic allergy","volume":"2","author":"Thong","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"issue":"4","key":"10.1016\/j.iac.2017.04.006_bib52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.all.0000173788.73401.69","article-title":"Cephalosporin chemical reactivity and its immunological implications","volume":"5","author":"Perez-Inestrosa","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2017.04.006_bib53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2003.09.035","article-title":"Detection of specific IgE to quinolones","volume":"113","author":"Manfredi","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.04.006_bib54","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/0091-6749(91)90186-R","article-title":"Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine","volume":"88","author":"Gruchalla","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2 pt 1","key":"10.1016\/j.iac.2017.04.006_bib55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/ai.1994.v94.a55251","article-title":"Vancomycin hypersensitivity: synergism with narcotics and \u201cdesensitization\u201d by a rapid continuous intravenous protocol","volume":"94","author":"Wong","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"27","key":"10.1016\/j.iac.2017.04.006_bib56","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.2174\/138161208786369812","article-title":"Macrolides allergy","volume":"14","author":"Ara\u00fajo","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.iac.2017.04.006_bib57","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.iac.2017.04.006_bib58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1200\/JCO.2000.18.1.102","article-title":"Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center","volume":"18","author":"Markman","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.iac.2017.04.006_bib59","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.iac.2017.04.006_bib60","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaci.2015.07.035","article-title":"Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions","volume":"137","author":"Lerondeau","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2017.04.006_bib61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00000542-198910000-00003","article-title":"Anaphylaxis following administration of papaveretum. Implications of IgE antibodies that react with morphine and codeine, and identification of an allergic determinant","volume":"71","author":"Harle","year":"1989","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.iac.2017.04.006_bib62","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.lpm.2016.02.024","article-title":"Epidemiology of perioperative anaphylaxis","volume":"45","author":"Mertes","year":"2016","journal-title":"La Presse M\u00e9dicale"},{"key":"10.1016\/j.iac.2017.04.006_bib63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/ACI.0000000000000292","article-title":"Angioedema associated with nonsteroidal anti-inflammatory drugs","volume":"16","author":"Giavina-Bianchi","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2017.04.006_bib64","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ACI.0b013e328355b8d3","article-title":"Hypersensitivity reactions to proton pump inhibitors","volume":"12","author":"Chang","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2017.04.006_bib65","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cea.12760","article-title":"Immediate-type hypersensitivity to polyethylene glycols: a review","volume":"46","author":"Wenande","year":"2016","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.iac.2017.04.006_bib66","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","article-title":"Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases","volume":"138","author":"Subramanian","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2017.04.006_bib67","first-page":"259","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.iac.2017.04.006_bib68","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.1994.12.12.2654","article-title":"European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion","volume":"12","author":"Eisenhauer","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.iac.2017.04.006_bib69","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000335631","article-title":"Immediate and delayed cutaneous reactions to radiocontrast media","volume":"97","author":"Brockow","year":"2012","journal-title":"Chem Immunol Allergy"},{"issue":"3","key":"10.1016\/j.iac.2017.04.006_bib70","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/pr.113.008425","article-title":"Pharmacology and signaling of Mas-related G protein-coupled receptors","volume":"66","author":"Solinski","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.iac.2017.04.006_bib71","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40121-016-0111-4","article-title":"Acute angioedema triggered by daptomycin","volume":"5","author":"Gisler","year":"2016","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.iac.2017.04.006_bib72","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2133.2002.04665.x","article-title":"Cutaneous adverse reactions to clindamycin: results of tests and oral exposure","volume":"146","author":"Lammintausta","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2017.04.006_bib73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000441-198407000-00011","article-title":"Anaphylaxis due to chloramphenicol","volume":"288","author":"Palchick","year":"1984","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.iac.2017.04.006_bib74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000091839","article-title":"Immediate hypersensitivity to rifampicin in 3 patients: diagnostic procedures and induction of clinical tolerance","volume":"140","author":"Buergin","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2017.04.006_bib75","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mai.2002.121533","article-title":"Case report: streptomycin-induced anaphylactic shock during oocyte retrieval process for in\u00a0vitro fertilization","volume":"109","author":"Iikura","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.04.006_bib76","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1183\/09031936.95.08050866","article-title":"Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement","volume":"8","author":"Wong","year":"1995","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.iac.2017.04.006_bib77","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0091270003253304","article-title":"Isoniazid-induced anaphylaxis","volume":"43","author":"Crook","year":"2003","journal-title":"Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.iac.2017.04.006_bib78","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00007890-200301150-00027","article-title":"Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression","volume":"75","author":"Lykavieris","year":"2003","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.iac.2017.04.006_bib79","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1600-6143.2004.00429.x","article-title":"Sirolimus-induced angioedema","volume":"4","author":"Wadei","year":"2004","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.iac.2017.04.006_bib80","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaad.2006.10.020","article-title":"Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors","volume":"56","author":"Krasowska","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2017.04.006_bib81","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajo.2004.02.035","article-title":"Angioedema related to the use of hyaluronidase in cataract surgery","volume":"138","author":"Eberhart","year":"2004","journal-title":"Am J Ophthalmol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856117300474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856117300474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T07:11:08Z","timestamp":1719299468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856117300474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0889856117300474"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2017.04.006","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2017.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}